Stock listing
GPW:PTG PolTREG Spolka Akcyjna Akcje
Follow PolTREG Spolka Akcyjna into a list and get an email when it puts out news.
Share price · GPW:PTG
17.90 PLN -0.40 (-2.2%)
Close on Nov 20, 2026
- Day range
- 17.90 – 18.70 PLNNov 20, 2026
- Volume
- 2,704 sharesNov 20, 2026
- Market cap
- 105.9M PLNAt the close on Nov 20, 2026 · price × 5.92M shares outstanding
- 52-week range
- 16.00 – 29.50 PLNLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- 91,899 PLNMedian day 2,828 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · GPW:PTG · PLN, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 17.90 | -0.40 | -2.2% | 18.15 | 18.70 | 17.90 | 2,704 | |
| 18.30 | -0.10 | -0.5% | 18.35 | 19.15 | 18.05 | 1,783 | |
| 18.40 | -0.60 | -3.2% | 18.95 | 18.95 | 18.40 | 554 | |
| 19.00 | -0.50 | -2.6% | 18.40 | 19.35 | 18.40 | 937 | |
| 19.50 | +0.20 | +1.0% | 19.25 | 19.50 | 18.30 | 2,828 | |
| 19.30 | +0.15 | +0.8% | 19.20 | 19.30 | 18.90 | 2,066 | |
| 19.15 | 0.00 | 0.0% | 19.20 | 19.20 | 18.00 | 15,337 | |
| 19.15 | -0.05 | -0.3% | 19.45 | 19.50 | 18.00 | 6,433 | |
| 19.20 | -0.80 | -4.0% | 20.00 | 20.00 | 19.00 | 6,597 | |
| 20.00 | -0.50 | -2.4% | 20.50 | 20.50 | 20.00 | 1,561 | |
| 20.50 | +0.85 | +4.3% | 19.95 | 20.50 | 19.60 | 1,432 | |
| 19.65 | -1.85 | -8.6% | 21.70 | 21.70 | 19.65 | 7,331 | |
| 21.50 | +0.20 | +0.9% | 21.20 | 21.60 | 20.00 | 3,663 | |
| 21.30 | +0.90 | +4.4% | 20.20 | 21.30 | 19.80 | 6,025 | |
| 20.40 | -0.20 | -1.0% | 20.70 | 20.70 | 19.25 | 7,073 | |
| 20.60 | 0.00 | 0.0% | 20.50 | 20.60 | 19.80 | 1,698 | |
| 20.60 | +0.50 | +2.5% | 19.70 | 20.60 | 19.50 | 1,980 | |
| 20.10 | 0.00 | 0.0% | 20.10 | 20.10 | 19.35 | 1,332 | |
| 20.10 | -0.50 | -2.4% | 20.10 | 20.20 | 19.80 | 111 | |
| 20.60 | -0.60 | -2.8% | 20.30 | 21.00 | 20.00 | 2,659 | |
| 21.20 | +1.50 | +7.6% | 20.90 | 21.20 | 20.00 | 3,644 | |
| 19.70 | -0.20 | -1.0% | 20.20 | 21.20 | 19.65 | 3,398 | |
| 19.90 | +0.35 | +1.8% | 19.15 | 20.20 | 19.15 | 3,356 | |
| 19.55 | +0.55 | +2.9% | 19.70 | 19.70 | 19.10 | 180 | |
| 19.00 | -0.55 | -2.8% | 20.00 | 20.00 | 19.00 | 3,072 | |
| 19.55 | -0.95 | -4.6% | 20.20 | 20.40 | 19.55 | 252 | |
| 20.50 | +0.75 | +3.8% | 19.80 | 20.50 | 19.15 | 2,617 | |
| 19.75 | +0.25 | +1.3% | 19.00 | 19.75 | 19.00 | 539 | |
| 19.50 | -0.05 | -0.3% | 20.10 | 20.20 | 19.00 | 12,094 | |
| 19.55 | -0.45 | -2.2% | 20.00 | 20.20 | 19.55 | 2,015 | |
| 20.00 | -0.30 | -1.5% | 19.65 | 20.20 | 19.65 | 807 | |
| 20.30 | -0.10 | -0.5% | 20.30 | 20.30 | 19.90 | 1,107 | |
| 20.40 | +0.10 | +0.5% | 20.00 | 20.40 | 19.20 | 2,474 | |
| 20.30 | -0.10 | -0.5% | 20.40 | 20.40 | 20.00 | 1,287 | |
| 20.40 | -0.10 | -0.5% | 19.80 | 20.70 | 19.60 | 4,187 | |
| 20.50 | -0.40 | -1.9% | 21.10 | 21.20 | 19.95 | 10,393 | |
| 20.90 | -0.80 | -3.7% | 21.60 | 21.60 | 20.00 | 8,180 | |
| 21.70 | +0.40 | +1.9% | 21.50 | 21.70 | 20.00 | 5,955 | |
| 21.30 | +0.60 | +2.9% | 20.80 | 21.30 | 20.50 | 2,176 | |
| 20.70 | +0.60 | +3.0% | 20.10 | 20.70 | 19.65 | 2,511 | |
| 20.10 | -0.20 | -1.0% | 20.00 | 20.20 | 19.10 | 8,574 | |
| 20.30 | -0.20 | -1.0% | 20.00 | 20.70 | 19.80 | 1,566 | |
| 20.50 | -0.50 | -2.4% | 20.20 | 21.10 | 19.95 | 8,387 | |
| 21.00 | 0.00 | 0.0% | 20.50 | 21.40 | 20.10 | 2,206 | |
| 21.00 | -0.70 | -3.2% | 21.40 | 21.70 | 19.70 | 13,345 | |
| 21.70 | -0.20 | -0.9% | 22.00 | 22.00 | 21.50 | 1,078 | |
| 21.90 | -1.00 | -4.4% | 22.90 | 23.00 | 21.90 | 4,366 | |
| 22.90 | +0.10 | +0.4% | 22.20 | 22.90 | 21.20 | 3,669 | |
| 22.80 | +0.40 | +1.8% | 22.30 | 22.80 | 22.00 | 1,453 | |
| 22.40 | +0.10 | +0.4% | 22.30 | 22.40 | 22.10 | 1,118 | |
| 22.30 | -0.90 | -3.9% | 23.20 | 23.20 | 22.10 | 4,311 | |
| 23.20 | +1.00 | +4.5% | 22.70 | 23.20 | 22.10 | 4,316 | |
| 22.20 | +0.30 | +1.4% | 22.30 | 23.40 | 22.20 | 8,419 | |
| 21.90 | -0.20 | -0.9% | 22.20 | 22.30 | 21.90 | 648 | |
| 22.10 | -1.00 | -4.3% | 23.10 | 23.10 | 21.80 | 6,720 | |
| 23.10 | +0.40 | +1.8% | 22.70 | 23.30 | 22.10 | 3,019 | |
| 22.70 | -0.80 | -3.4% | 23.50 | 23.50 | 22.00 | 6,215 | |
| 23.50 | -0.10 | -0.4% | 23.00 | 23.60 | 22.70 | 2,664 | |
| 23.60 | 0.00 | 0.0% | 23.00 | 23.60 | 23.00 | 2,903 | |
| 23.60 | -0.10 | -0.4% | 23.20 | 24.20 | 22.80 | 4,667 | |
| 23.70 | -1.30 | -5.2% | 24.70 | 24.70 | 22.50 | 19,983 | |
| 25.00 | -0.20 | -0.8% | 25.00 | 25.50 | 24.00 | 12,502 | |
| 25.20 | -1.40 | -5.3% | 26.40 | 26.70 | 24.50 | 9,828 | |
| 26.60 | +0.10 | +0.4% | 26.50 | 26.70 | 25.60 | 1,685 | |
| 26.50 | +0.90 | +3.5% | 25.60 | 26.50 | 25.30 | 1,523 |
- Ticker
- GPW:PTG
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- GPW
- Currency
- PLN
What changed lately
Latest news release · Mar 10, 2026
PolTREG moves forward with the European registration process for TREG therapy in type 1 diabetes
Latest deck · February 2026
PolTREG — Investor Presentation (February 2026)
Investor deck · 33 slides
Latest news
PolTREG moves forward with the European registration process for TREG therapy in type 1 diabetes
Mar 10, 2026
Closed 24.10 (-1.6%) on Mar 10, 2026
PolTREG Spolka Akcyjna on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 1 in the last 12 months · 15 in all · newest Mar 10, 2026 · oldest 2024
- Decks
- 15 decks · latest February 2026
Valuation
EV/sales 378× against a median of −13.9×: the highest of 3 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- 90.74M PLN
- P/E
- Loss
- EV/sales
- 378×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 2.2×
- Gross margin
- Revenue too small
- Operating margin
- Revenue too small
- Net margin
- Revenue too small
- Debt to equity
- 0.1×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| PolTREG Spolka Akcyjna · GPW:PTG | US$26.09M | US$22.35M | n/a | 378× | n/a | 2.2× | n/a | 0.1× | n/a |
| Edesa Biotech, Inc. · NASDAQ:EDSA | US$27.02M | US$16.72M | n/a | n/a | n/a | 3.1× | n/a | 0.0× | 0.47 |
| Amplia Therapeutics Ltd. · ASX:ATX | US$26.84M | US$8.63M | n/a | n/a | n/a | 1.0× | n/a | 0.0× | n/a |
| Nasus Pharma Ltd. · AMEX:NSRX | US$26.82M | US$15.11M | n/a | n/a | n/a | 2.4× | n/a | 0.0× | 0.99 |
| Telomir Pharmaceuticals, Inc. · NASDAQ:TELO | US$26.82M | US$22.30M | n/a | n/a | n/a | 6.1× | n/a | 0.0× | 1.74 |
| BriaCell Therapeutics Corp · TSX:BCT | US$26.79M | US$6.25M | n/a | n/a | n/a | 1.7× | n/a | 0.0× | 1.07 |
| Alterity Therapeutics Ltd. · ASX:ATH | US$26.76M | US$2.18M | n/a | n/a | n/a | 0.9× | n/a | 0.0× | n/a |
| EyePoint, Inc. · NASDAQ:EYPT | US$26.65M | −US$72.44M | n/a | −28.1× | n/a | 0.3× | n/a | 0.2× | 1.36 |
| Aprogen, Inc · KRX:007460 | US$26.64M | US$21.31M | n/a | 0.2× | n/a | 0.6× | −60.1% | 0.6× | n/a |
| Launxp Biomedical Co., Ltd. · TPEX:6876 | US$25.67M | US$11.86M | n/a | n/a | n/a | 2.3× | n/a | 0.0× | n/a |
| INmune Bio Inc. · NASDAQ:INMB | US$25.60M | US$10.48M | n/a | n/a | n/a | 1.4× | n/a | 0.1× | 2.63 |
| Median of the others | US$26.77M | US$11.17M | −13.9× | 1.6× | −60.1% | 0.0× | 1.22 |
Forecasts
Analysts' consensus from EODHD, read Nov 21, 2026. Not 6ix's view and not investment advice.
- Price target
- 29.30 PLN · Analysts' mean
- EPS, year to Dec 2026
- -5.50 · 1 analyst
- Revenue, year to Dec 2026
- 800K · 1 analyst
Team and board
| Officer | Role |
|---|---|
| Piotr Trzonkowski | Chief Executive Officer |
| Dan Shelly | Chief Business Development Officer |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q2 2026 | Sep 10, 2026 | +2.2% |
| Q1 2026 | May 21, 2026 | +2.3% |
| Q3 2025 | Dec 3, 2025 | −9.4% |
| Q2 2025 | Sep 3, 2025 | −5.7% |
| Q1 2025 | May 28, 2025 | −3.4% |
| Q3 2024 | Nov 27, 2024 | −4.5% |
| Q2 2024 | Sep 12, 2024 · After close | −2.3% |
| Q1 2024 | May 23, 2024 · After close | −0.2% |
| Q4 2023 | Feb 28, 2024 | +2.3% |
| Q3 2023 | Nov 29, 2023 | −1.9% |
All 15 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q2 2023 | Aug 30, 2023 | −3.8% |
| Q1 2023 | May 31, 2023 | −2.9% |
| Q4 2022 | Mar 1, 2023 | +2.6% |
| Q3 2022 | Nov 30, 2022 | +2.1% |
| Q1 2022 | Apr 29, 2022 · After close | +1.9% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| PolTREG — Investor Presentation (February 2026) | Investor deck | 33 slides | February 2026 |
| PolTREG — Investor Presentation (September 2024) | Investor deck | 30 slides | Sep 13, 2024 |
| PolTREG — Investor Presentation (March 2024) | Investor deck | 23 slides | Mar 7, 2024 |
| PolTREG — Investor Presentation (February 2024) | Investor deck | 28 slides | Feb 26, 2024 |
| PolTREG — Investor Presentation (January 2024) | Investor deck | 23 slides | Jan 30, 2024 |
| PolTREG — Investor Presentation (December 2023) | Investor deck | 28 slides | Dec 19, 2023 |
| PolTREG — Q3 2023 Earnings Presentation | Earnings | 21 slides | Nov 23, 2023 |
| PolTREG — Corporate Update (June 2023) | Corporate update | 65 slides | Jun 19, 2023 |
| PolTREG — Investor Presentation (April 2023) | Investor deck | 21 slides | April 2023 |
| PolTREG — Investor Presentation (January 2023) | Investor deck | 26 slides | January 2023 |
All 15 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| PolTREG — Investor Presentation (December 2022) | Investor deck | 27 slides | Dec 6, 2022 |
| PolTREG — Q3 2022 Earnings Presentation | Earnings | 35 slides | Nov 28, 2022 |
| PolTREG — Trigon Tech Conference 2022 | Conference | 26 slides | September 2022 |
| PolTREG — Investor Presentation (May 2022) | Investor deck | 34 slides | May 2022 |
| PolTREG — Investor Presentation (December 2021) | Investor deck | 28 slides | December 2021 |
Financials
Annual, in PLN
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 350.0K | 1.40M | 999.0K | 1.10M | 700.0K | 500.0K | 0 |
| Cost of revenue | 5.66M | 4.79M | 2.79M | 1.12M | 282.0K | 243.0K | 278.0K | 105.0K |
| Gross profit | -5.66M | -4.45M | -1.39M | -124.0K | 817.0K | 457.0K | 222.0K | -105.0K |
| Selling, general and administrative | 4.79M | 3.59M | 3.96M | 3.50M | 2.47M | 1.20M | 816.0K | 543.0K |
| Operating income | -35.5M | -20.3M | -16.9M | -5.23M | -3.48M | -955.0K | -680.0K | -1.26M |
| Depreciation and amortization | 5.66M | 4.01M | 1.05M | 823.0K | 575.0K | 557.0K | 567.0K | 310.0K |
| EBITDA | -29.9M | -16.3M | -15.8M | -4.41M | -2.90M | -398.0K | -113.0K | -950.0K |
| Interest expense | 929.0K | 837.0K | 356.0K | 301.0K | 41.0K | 104.0K | 198.0K | 249.0K |
| Income before tax | -26.0M | -18.7M | -13.6M | -1.97M | -3.74M | -878.0K | -967.0K | -1.35M |
| Income tax | -3.27M | 41.0K | 198.0K | |||||
| Net income | -26.0M | -18.7M | -13.6M | -1.97M | -3.74M | -878.0K | -967.0K | -1.35M |
| Earnings per share, basic | -5.58 | -4.01 | -2.91 | -0.42 | -1.09 | -0.26 | -0.29 | -0.41 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 17.8M | 45.7M | 66.0M | 90.0M | 103.9M | 15.1M | 5.17M | 7.91M |
| Receivables | 4.64M | 1.70M | 5.58M | 9.33M | 795.0K | 253.0K | 126.0K | 28.0K |
| Inventory | 1.16M | 727.0K | 415.0K | 83.0K | 0 | 5.00K | 0 | 0 |
| Current assets | 23.6M | 48.1M | 72.0M | 99.5M | 106.0M | 15.6M | 5.63M | 9.05M |
| Property, plant and equipment | 22.8M | 2.08M | 656.0K | 1.21M | 1.42M | |||
| Total assets | 73.0M | 102.4M | 127.1M | 123.3M | 109.1M | 16.2M | 6.84M | 10.5M |
| Accounts payable | 1.12M | 856.0K | 1.25M | 862.0K | 294.0K | 56.0K | 393.0K | 245.0K |
| Current liabilities | 10.1M | 11.5M | 18.5M | 13.8M | 5.68M | 3.00M | 4.34M | 2.46M |
| Long-term debt | 0 | 9.00K | 294.0K | 406.0K | 2.61M | |||
| Total debt | 7.62M | 7.97M | 8.19M | 7.90M | 178.0K | 763.0K | 2.04M | 4.07M |
| Total liabilities | 17.2M | 33.1M | 39.6M | 22.3M | 6.12M | 3.41M | 6.85M | 9.70M |
| Shareholders' equity | 43.3M | 69.2M | 87.5M | 101.0M | 103.0M | 12.8M | -6.00K | 764.0K |
| Shares outstanding | 4.66M | 4.66M | 4.66M | 4.66M | 3.42M | 3.33M | 3.33M | 3.33M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | -28.7M | -16.0M | -13.3M | -8.60M | -3.84M | -2.79M | -1.19M | -1.04M |
| Capital spending | -543.0K | -8.75M | -31.6M | -7.58M | -2.97M | -2.97M | -421.0K | -103.0K |
| Free cash flow | -29.2M | -25.6M | -44.9M | -16.2M | -6.80M | -2.79M | -1.61M | -1.15M |
| Cash from investing | -547.0K | -8.75M | -31.6M | -5.05M | -454.0K | 362.0K | 417.0K | 4.72M |
| Cash from financing | 1.35M | 4.46M | 20.8M | 2.28M | 93.2M | 12.3M | -1.96M | -47.0K |
| Change in cash | -27.9M | -20.3M | -24.1M | -13.9M | 88.9M | 9.88M | -2.73M | 3.63M |
Cap table
Built by 6ix from PolTREG Spolka Akcyjna’s releases
- Common shares
- 5,916,456
- Fully diluted
- 5,916,456
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 5,916,456 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 5,916,456 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Dan Shelly | Chief Business Development Officer · Since at least Jun 13, 2025 |
| Piotr Trzonkowski | Chief Executive Officer · Since at least Mar 10, 2026 |
Log in to ask 6ix AI your own questions about PolTREG Spolka Akcyjna.